SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3,612.94 |
| Enterprise Value ($M) | 3,238.25 |
| Book Value ($M) | 352.62 |
| Book Value / Share | 2.08 |
| Price / Book | 10.25 |
| NCAV ($M) | 344.23 |
| NCAV / Share | 2.03 |
| Price / NCAV | 10.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.09 |
| Return on Assets (ROA) | -0.54 |
| Return on Equity (ROE) | -0.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.04 |
| Current Ratio | 6.04 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 412.54 |
| Assets | 420.93 |
| Liabilities | 68.31 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Non Redeemable Common Stock Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Roivant Sciences Ltd. | |||
| 13G/A | Fmr Llc | 8.56 | 59.19 | |
| 13G/A | Deep Track Capital, LP | 0.69 | -89.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 234,011 | 816,204 | 28.67 | |
| 216,324 | 727,574 | 29.73 | |
| 199,529 | 846,788 | 23.56 | |
| 167,074 | 788,354 | 21.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IFRX – InflaRx N.V. | IGMS – IGM Biosciences, Inc. |
| IMUX – Immunic, Inc. | INBX – Inhibrx Biosciences, Inc. |
| INDV – Indivior PLC |
Financial data and stock pages provided by
Fintel.io